UPDATE: Goldman Sachs Starts Oak Street Health (OSH) at Buy

Go back to UPDATE: Goldman Sachs Starts Oak Street Health (OSH) at Buy

UPDATE: Morgan Stanley Starts Oak Street Health (OSH) at Equalweight

August 31, 2020 4:43 AM EDT

(Updated - August 31, 2020 5:54 AM EDT)

(updating comment)

Morgan Stanley analyst Ricky Goldwasser initiates coverage on Oak Street Health (NYSE: OSH) with a Equalweight rating and a price target of $50.00.

The analyst comments "Oak Streets differentiated primary care platform for Medicare... More

UPDATE: Baird Starts Oak Street Health (OSH) at Outperform

August 31, 2020 3:31 AM EDT

(Updated - August 31, 2020 8:06 AM EDT)

(updating comment)

Baird analyst Matthew Gillmor initiates coverage on Oak Street Health (NYSE: OSH) with a Outperform rating and a price target of $55.00.

The analyst comments "Our positive thesis is based on the following points: (1) OSHs... More

JPMorgan Starts Oak Street Health (OSH) at Overweight

August 31, 2020 3:18 AM EDT

JPMorgan analyst Gary Taylor initiates coverage on Oak Street Health (NYSE: OSH) with a Overweight rating and a price target of $52.00.


For an analyst ratings summary and ratings history on Oak Street Health... More

UPDATE: Piper Sandler Starts Oak Street Health (OSH) at Overweight

August 31, 2020 3:01 AM EDT

(Updated - August 31, 2020 5:45 AM EDT)

(updating comment)

Piper Sandler analyst Sean Wieland initiates coverage on Oak Street Health (NYSE: OSH) with a Overweight rating and a price target of $54.00.

The analyst comments "Oak Street Health is Primary Care V2.0... More